Provided herein is a neutral electrolyzed water or activated saline or gel formulation thereof. The neutral electrolyzed water comprises active species of chlorine and oxygen [Cl/O] at a concentration of about 0.00001% (0.1 ppm) to about 0.004% (40 ppm) and sodium chloride at a concentration of about 3% or less in reverse osmosis water. The neutral electrolyzed water or formulations are useful when administered or delivered to a subject for reducing bleeding or inducing hemostasis during a procedure, for reducing inflammation, for reducing pain, for regenerating or repairing a tissue or organ, and/or for modulating activity of the immune system to control chronic inflammation and/or exacerbated oxidant stress and for inducing a therapeutic effect.

The present invention provides a method of treating neuropathic pain by administering a topical homeopathic composition to a mammalian subject. The homeopathic formulation contains homeopathic active ingredients comprising Hypericum perforatum in a base of essential oils which facilitate delivery of the homeopathic ingredient through the skin.

The present invention is a method for controlling a regeneration speed of an animal cell that includes a step of grasping tide-generating force and a step of giving a physical or chemical stimulus to the animal cell according to the magnitude of variation in the tide-generating force.

The present invention relates to a homeopathic formulation comprising dilutions of Arnica, Calendula, Echinacea, Hypericum, Silver, Sulfur, Thiosinaminum, Urtica, and methods for treating pain, inflammation, scar tissue, itching/pruritus and infection using same.

Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions.

A homeopathic mixture for relieving fatigue symptoms or cancer treatment related fatigue symptoms or radiation fatigue symptoms that includes cadmium sulphuratum, x-ray, phosphoricum acidum, radium bromatum, and carbo animalis. The cadmium sulphuratum is diluted not less than twelve times and not more than two hundred times, the x-ray is diluted not less than three times and not more than thirty times, the phosphoricum acidum is diluted not less than twelve times and not more than two hundred times, the radium bromatum is diluted not less than twelve times and not more than two hundred times, and the carbo animalis is diluted not less than twelve times and not more than two hundred times, all on a scale of 1:100.

The present invention relates to water for use as a medicament, characterized in that to the water, electromagnetic energies in the form of: (i) light energy with a wavelength of between 500 and 700 nm, (ii) light energy with a wavelength of between 701 and 1050 nm, and (iii) an electrical energy with a maximum voltage of 240 V, are simultaneously applied, wherein at least one of the electromagnetic energies (i), (ii) and (iii) is applied to the water in the form of trains of pulses having at least two discrete frequencies, wherein a first frequency is between 0.1 to 10 Hz and a second frequency is between 40 and 1500 Hz.

This invention includes an electrolysis chamber and method for producing controlled flow acid electrolyzed water and controlled flow alkaline electrolyzed water with independent flows from aqueous solutions. Its objective is to produce controlled flow acid water with an oxide reduction potential (ORP) between +1100 and +1200 mV and a pH between 1.5 and 2.9 with a stability and shelf life of over a year, and controlled flow alkaline electrolyzed water with a pH between 9.0-11.0 and an ORP between 700 mV to 800 mV with a shelf life of more than a year.

This invention includes an electrolysis chamber and method for producing controlled flow acid electrolyzed water and controlled flow alkaline electrolyzed water with independent flows from aqueous solutions. Its objective is to produce controlled flow acid water with an oxide reduction potential (ORP) between +1100 and +1200 mV and a pH between 1.5 and 2.9 with a stability and shelf life of over a year, and controlled flow alkaline electrolyzed water with a pH between 9.0-11.0 and an ORP between 700 mV to 800 mV with a shelf life of more than a year.

The present invention provides a method including: a magnet, hand-modes made by human hand positioning to generate a charge or vibrational frequency, and a material for the hand-mode's charge to be transferred into. The charged material is then used to charge other materials using a magnet, the charged material, and the new material to be charged.